Mozaffarian reports research funding from the National Institutes of Health, Kaiser Permanente Fund at the East Bay Community Foundation, National Association of Chain Drug Stores Foundation, Google Health, and The Rockefeller Foundation
Anbazhagan AN, Thaqi M, Priyamvada S, Jayawardena D, Kumar A, Gujral T, Chatterjee I, Mugarza E, Saksena S, Onyuksel H, Dudeja PK (2017) GLP-1 nanomedicine alleviates gut inflammation
GLP-1 behavioral shifts tend to affect margin mix before they affect total revenue, which is why they're easy to miss until the margin pressure is already entrenched
It also helps reduce cholesterol and triglyceride levels, lowering the risk of cardiovascular disease and possesses anti-inflammatory properties that contribute to overall health benefits